Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Functional plasticity in MS: Friend or foe?
Spatial modeling of multiple sclerosis for disease subtype prediction.
Biomarkers of treatment response in multiple sclerosis.
Vitamin D and multiple sclerosis: what is the clinical impact?
Brain Innate Immunity In The Regulation Of Neuroinflammation: Therapeutic Strategies By Modulating Cd200-Cd200r Interaction Involve The Cannabinoid System.
Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.
Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
The role of diet in multiple sclerosis.
Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Treatment of primary progressive multiple sclerosis.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Assessment of visual disability using visual evoked potentials.
Mechanics in Neuronal Development and Repair.
Pages
« first
‹ previous
…
212
213
214
215
216
217
218
219
220
…
next ›
last »